Clinical Competence Is the Cornerstone of Ig Outcomes
Originally published by our sister publication Specialty Pharmacy ContinuumAmy E. Clarke, DNP, RN, IgCN®Chief Clinical OfficerImmunoglobulin National SocietyCalabasas, CaliforniaLuba Sobolevsky, PharmD, IgCP®President and CEOImmunoglobulin National SocietyCalabasas, CaliforniaImmunoglobulin (Ig) therapy is one of the most resource-intensive treatments in the infusion pharmacy landscape. With substantial annual per-patient costs that vary by indication, dose, and site of care, and a patie
Read more »
Pharmacy news
Managing IBD Patients With Few Options Left
5-Year POSITIVE Data Reassure on Pregnancy in Breast Cancer
Rethinking Iron Deficiency Anemia
The Value of the ACHC/IgNS Distinction in Immunoglobulin Therapy
Are We on Shaky Ground With Medication Adherence?
Targeting CD4 to Treat HIV
An Oklahoma Health System’s Road to Dual-Specialty Pharmacy Accreditation
Rapid Sepsis Test Could Reduce Mortality, Improve Resource Utilization in the ED
Get Ready for CMS’s 2027 Outpatient Payment Shake-up
Pharmacists Primed to Help Transform Primary Care Delivery
From Manure Pits to Superwarfarins: Rural Toxicology’s Biggest Challenges
340B Rebate Pilot: What Hospitals Need to Do Now Before Possible 2027 Launch
New Executive Order on Vaccine Policy Reasserts Misinformation and Spurs Confusion, Experts Say
Ifosfamide Shortage Strains Curative Regimens as Platinum Worries Return
